Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|August 29, 2000
Interim analysis of a phase III trial. Triple- vs double-agent chemotherapy for advanced non-small-cell lung cancer. Southern Italy Cooperative Oncology GroupP Comella
Seminars in Oncology|May 24, 2001
Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancerP Comella,
Anti-Cancer Drugs|April 20, 2001
[Gemcitabine + Cisplatin combinations in advanced non-small cell lung cancer]P Comella,
Anti-Cancer Drugs|July 19, 2001
Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapyF Caponigro, A Avallone, A Budillon, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, and bleomycinP Comella, G Abate, G Di Finizio, et al.
Tumori|April 30, 1986
Urinary neopterin levels in hematologic malignanciesG Santelli, A Marfella, G Abate, et al.
Tumori|December 31, 1980
Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary resultsP Comella, G Abate, G Comella, et al.
Tumori|July 1, 1996
Weekly low dose epirubicin in elderly cancer patientsD Nicolella, G Grimaldi, G Colantuoni, et al.
Gynecologic Oncology|July 1, 1995
Carboplatin (CBDCA)-hexamethylmelamine (HMM)-oral etoposide (VP-16) first-line treatment of ovarian cancer patients with bulky disease: a phase II studyG Frasci, G Comella, P Comella, et al.
Cancer|February 1, 1989
Prognostic relevance of urinary neopterin in non-Hodgkin's lymphomasG Abate, P Comella, A Marfella, et al.
Pageof 9